For virologically suppressed adult patients with HIV-1. See Full Indication.

JULUCA | Prescribing Information

Full Prescribing Information

Refer to the full Prescribing Information for additional details about JULUCA, including dosage and administration and drug interactions. The Prescribing Information also includes information about SWORD 1 & 2 trials in virologically suppressed* adult patients with HIV-1.

PRESCRIBING INFO

Click to view the full Prescribing Information for JULUCA

Read more »

*HIV-1 RNA <50 copies/mL on a stable antiretroviral therapy for at least 6 months.

You may also be interested in

CLINICAL TRIALS

Read more »

RISKS & SIDE EFFECTS

Read more »

PATIENT SUPPORT

Read more »